DE3069560D1 - Cephem compounds, processes for their preparation and pharmaceutical compositions containing them - Google Patents

Cephem compounds, processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
DE3069560D1
DE3069560D1 DE8080105160T DE3069560T DE3069560D1 DE 3069560 D1 DE3069560 D1 DE 3069560D1 DE 8080105160 T DE8080105160 T DE 8080105160T DE 3069560 T DE3069560 T DE 3069560T DE 3069560 D1 DE3069560 D1 DE 3069560D1
Authority
DE
Germany
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
cephem compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080105160T
Other languages
English (en)
Inventor
Takao Takaya
Hisashi Takasugi
Masayoshi Murata
Akiteru Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3069560D1 publication Critical patent/DE3069560D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE8080105160T 1979-09-03 1980-08-29 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them Expired DE3069560D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7930515 1979-09-03
GB8018006 1980-06-02

Publications (1)

Publication Number Publication Date
DE3069560D1 true DE3069560D1 (en) 1984-12-06

Family

ID=26272750

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080105160T Expired DE3069560D1 (en) 1979-09-03 1980-08-29 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them

Country Status (4)

Country Link
US (2) US4394384A (de)
EP (2) EP0025199B1 (de)
JP (1) JPS63258469A (de)
DE (1) DE3069560D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3177090D1 (en) * 1980-12-31 1989-09-28 Fujisawa Pharmaceutical Co 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
NO832376L (no) * 1982-06-30 1984-01-02 Glaxo Group Ltd Cephalosporin-antibiotika.
US4616081A (en) * 1982-07-07 1986-10-07 Asahi Kasei Kogyo Kabushiki Kaisha Cephalosporin compounds
US4652651A (en) * 1983-05-31 1987-03-24 Hoffmann-La Roche Inc. Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage
JPS60132983A (ja) * 1983-12-21 1985-07-16 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体及びその製法
US4918067A (en) * 1986-07-24 1990-04-17 Beecham Group P.L.C. Heterocyclic substituted penicillin antibiotics
GB0010475D0 (en) * 2000-04-28 2000-06-14 Biochemie Gmbh Organic compounds
EP2862569A1 (de) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Verfahren zur Behandlung von intrapulmonalen Infektionen
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4196205A (en) * 1976-01-23 1980-04-01 Roussel Uclaf 3-Acetoxymethyl-7-(iminoacetamido)-cephalosporanic acid derivatives
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
DE2714880A1 (de) 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4370326A (en) * 1977-09-13 1983-01-25 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and composition

Also Published As

Publication number Publication date
JPS63258469A (ja) 1988-10-25
EP0088454A2 (de) 1983-09-14
JPH0316350B2 (de) 1991-03-05
EP0088454B1 (de) 1986-03-05
EP0025199B1 (de) 1984-10-31
US4394384A (en) 1983-07-19
EP0088454A3 (en) 1983-11-09
EP0025199A2 (de) 1981-03-18
US4529802A (en) 1985-07-16
EP0025199A3 (en) 1981-05-13

Similar Documents

Publication Publication Date Title
DE2967410D1 (en) Cephem and cepham compounds, processes for their preparation, pharmaceutical compositions containing them
DE2966293D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE2966913D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE3064173D1 (en) Novel 20-0-acylmaytansinoids, process for their preparation and pharmaceutical compositions containing them
DE3065949D1 (en) Naphthyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3070286D1 (en) 7-acylamino-3-substituted cephalosporanic acid derivatives, processes for their preparation and pharmaceutical compositions containing them
DE3279470D1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
EP0133678A3 (en) New cephem compounds, processes for preparation thereof and pharmaceutical compositions containing them
DE3279649D1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and intermediate products for their preparation
DE3275997D1 (en) New cephem compounds, processes for their preparation and pharmaceutical antibacterial composition containing them
DE3069560D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE3069364D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE3176154D1 (en) Cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
DE3060861D1 (en) Monophosphonate compounds, process for their preparation and pharmaceutical compositions containing them
IL61264A (en) Dihydro-piperazinylpyrazolobenzodiazepine compounds,their preparation and pharmaceutical compositions containing them
DE3068410D1 (en) Analogous compounds of cephalosporins, processes for their preparation, and pharmaceutical composition containing them
DE3062972D1 (en) Pyridazopyridazine derivatives, processes for their preparation and pharmaceutical compositions containing these pyridazopyridazine derivatives
EP0018077A3 (en) Phenylmorphans, processes for their preparation, pharmaceutical compositions containing them, and 4-phenyl-tetrahydro-pyridines
DE3067174D1 (en) Tetrahydro-fluorene compounds, processes for their preparation and pharmaceutical compositions thereof
IL61099A (en) 9-deoxy-6,9alpha-imino-delta6,8-pgi analogues,process for their preparation and pharmaceutical compositions containing them
DE3063160D1 (en) Spiro compounds, process for their preparation and pharmaceutical compositions containing them
DE3070258D1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE3372968D1 (en) Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use
DE3060137D1 (en) Spiro-quinolone hydantoins, pharmaceutical compositions containing them, and processes for their preparation
IL69107A (en) 15-hydroxyimino-14-oxo-eburnamenine derivatives,process for their preparation and pharmaceutical compositions containing these compounds

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee